Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Elanco Animal Health
5EACurrent price
13.03 EUR
0 EUR (0.00%)
Last closed
14.52 USD
Company
www.elanco.com
ISIN
US28414H1032
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Exchange
Frankfurt Exchange
Capitalization
7 459 364 352 USD
Yield for 12 month
+20.87 %
1Y
3Y
5Y
10Y
15Y
5EA
Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet health therapeutics for pain, osteoarthritis, ear infections, cardiovascular, and dermatology indications in canines and felines under the Galliprant and Claro brands; vaccines, antibiotics, parasiticides, and other products for use in poultry and aquaculture production, as well as nutritional health products, including enzymes, probiotics, and prebiotics; and a range of vaccines, antibiotics, implants, parasiticides, and other products used in ruminant and swine production under the Rumensin and Baytril brands. The company sells its products to third-party distributors; veterinarians; and farm animal producers, including beef and dairy farmers, as well as pork, poultry, and aquaculture operations. Elanco Animal Health Incorporated was founded in 1954 and is headquartered in Greenfield, Indiana. Address: 2500 Innovation Way, Greenfield, IN, United States, 46140
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
19.23 USDP/E ratio
–Dividend Yield
–Current Year
+4 417 000 000 USD
Last Year
+4 418 000 000 USD
Current Quarter
+1 184 000 000 USD
Last Quarter
+1 205 000 000 USD
Current Year
+2 486 000 000 USD
Last Year
+2 505 000 000 USD
Current Quarter
+558 000 000 USD
Last Quarter
+690 000 000 USD
Key Figures 5EA
1 year
3 years
5 years
10 years
EBITDA
925 000 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
1.3 %
PEG Ratio
1.8448
Return On Equity TTM
-18.79 %
Wall Street Target Price
19.23 USD
Revenue TTM
4 492 000 256 USD
Book Value
12.02 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
12 %
Dividend Yield
–
Gross Profit TTM
2 498 000 000 USD
Earnings per share
-2.55 USD
Diluted Eps TTM
-2.55 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
-71.4 %
Profit Margin
-27.94 %
Dividend Analytics 5EA
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History 5EA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation 5EA
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
14.3678
Enterprise Value Revenue
2.8316
Price Sales TTM
1.6606
Enterprise Value EBITDA
-55.7862
Price Book MRQ
1.2554
Financials 5EA
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators 5EA
For 52 weeks
8.52 USD
18.8 USD
50 Day MA
13.81 USD
Shares Short Prior Month
13 890 079
200 Day MA
14.96 USD
Short Ratio
2.09
Shares Short
12 077 023
Short Percent
3.92 %
BeatStart